Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for post-RFA neuritis prevention
NCT03247413Phase 4Terminated
- Sponsor
- Johns Hopkins University
- Start
- Sep 2019
- Primary completion
- Oct 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexamethasone in neuritis, sponsored by Johns Hopkins University. Primary endpoint: Number of Lesions With Post-Ablation Neuritis at 4 weeks. Started Sep 2019; status: terminated.
02
Drugs
dexamethasone
03
Conditions
neuritis
Beyond the preview
Go deeper on NCT03247413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03247413.